Przejdź do zawartości
· Biorewitalizacja
SKU 13756

Sunekos Cell 15

Dostępny
Laboratorium
Professional Dietetics S.p.A.
Pochodzenie
Włochy
Wskazanie
Cellulite, EFP, stages I to IV
Cena hurtowa i historia tylko dla zweryfikowanych
allpara zaopatruje licencjonowanych specjalistów. Zaloguj się lub załóż konto B2B, aby zobaczyć aktualne ceny, progi ilościowe i historię cen.

Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is suitable for qualified practitioners treating cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product relies on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach and is intended for professional use.

Najważniejsze zalety: Sunekos Cell 15

  • CE-marked Class III medical device
  • Promotes optimisation of extracellular matrix protein turnover
  • Supports neo-collagenesis rather than collagenase
  • Helps improve microcirculation
  • Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
  • Helps regulate physiological pH
  • Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
  • Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
Najważniejsze informacje
Marka Sunekos
Producent Professional Dietetics S.p.A.
Kraj pochodzenia Italy
Certyfikacja CE-marked Class III medical device
Skład Low molecular weight (200 kD) sodium hyaluronate with the patented HY6AA amino acid formula (glycine, L-proline, L-lysine, L-leucine, L-valine, L-alanine), plus carbonate and bicarbonate salts that rebalance the acidosis of the latent inflammation seen in both early and late stage cellulite
Objętość / Rozmiar 15 ml per reconstituted treatment pack
Opakowanie 1 treatment pack of 15 ml to be reconstituted: 1 vial of carbonate/bicarbonate and 1 bottle of low molecular weight sodium hyaluronate with amino acids
Rozmiar igły ATL-n needle technique (stages I and II): 30 G, 12 mm. ATL-c cannula technique (stages III and IV): 27 G, 40-50 mm, or 22 G, 50-70 mm.
Rodzaj zastosowania Professional use only, by qualified practitioners. Supplied as a pack to be reconstituted before use.
Głębokość iniekcji ATL-n needle technique, for stages I and II: medium-deep dermis, needle inclination 30 degrees, 0.15 ml per point, perpendicular to the folding lines. ATL-c cannula technique, for stages III and IV: deep dermis injection, fan technique, 0.8 ml per injection.
Protokół / Czas trwania Injection scheme: 3 areas per side at 2.5 ml per area, giving 7.5 ml per leg.

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
  • Cellulite stages I and II
  • Cellulite stages III and IV
  • Fibrosis and extracellular matrix inflammation associated with cellulite
  • Impaired microcirculation associated with cellulite

Zastosowanie profesjonalne

Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.

Obszary zabiegowe

  • Cellulite-affected areas of the thighs and gluteal/trochanteric region

Profil pacjenta

Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.

Jak działa Sunekos Cell 15 ​

Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty SUNEKOS od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z oznakowaniem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z indywidualnym wsparciem posprzedażowym dla Twojego spokoju.

Najczęściej zadawane pytania

Which cellulite stages does Sunekos Cell 15 treat?

Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.

How does Sunekos Cell 15 differ from lipolytic cellulite treatments?

Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.

Why does Sunekos Cell 15 include an alkaline solution?

The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.

Więcej od Professional Dietetics

Zobacz laboratorium

Alternatywy dla kliniki

Wszystkie produkty

Sunekos Cell 15

Dostępny
Oznakowanie CE Oznakowanie CE Sunekos Cell 15
Ceny tylko dla zweryfikowanych
Zaloguj się lub załóż konto B2B, aby zobaczyć swoją cenę.
Konto B2B

Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is suitable for qualified practitioners treating cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product relies on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach and is intended for professional use.

Najważniejsze zalety: Sunekos Cell 15

  • CE-marked Class III medical device
  • Promotes optimisation of extracellular matrix protein turnover
  • Supports neo-collagenesis rather than collagenase
  • Helps improve microcirculation
  • Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
  • Helps regulate physiological pH
  • Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
  • Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
Najważniejsze informacje
Marka Sunekos
Producent Professional Dietetics S.p.A.
Kraj pochodzenia Italy
Certyfikacja CE-marked Class III medical device
Skład Low molecular weight (200 kD) sodium hyaluronate with the patented HY6AA amino acid formula (glycine, L-proline, L-lysine, L-leucine, L-valine, L-alanine), plus carbonate and bicarbonate salts that rebalance the acidosis of the latent inflammation seen in both early and late stage cellulite
Objętość / Rozmiar 15 ml per reconstituted treatment pack
Opakowanie 1 treatment pack of 15 ml to be reconstituted: 1 vial of carbonate/bicarbonate and 1 bottle of low molecular weight sodium hyaluronate with amino acids
Rozmiar igły ATL-n needle technique (stages I and II): 30 G, 12 mm. ATL-c cannula technique (stages III and IV): 27 G, 40-50 mm, or 22 G, 50-70 mm.
Rodzaj zastosowania Professional use only, by qualified practitioners. Supplied as a pack to be reconstituted before use.
Głębokość iniekcji ATL-n needle technique, for stages I and II: medium-deep dermis, needle inclination 30 degrees, 0.15 ml per point, perpendicular to the folding lines. ATL-c cannula technique, for stages III and IV: deep dermis injection, fan technique, 0.8 ml per injection.
Protokół / Czas trwania Injection scheme: 3 areas per side at 2.5 ml per area, giving 7.5 ml per leg.

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
  • Cellulite stages I and II
  • Cellulite stages III and IV
  • Fibrosis and extracellular matrix inflammation associated with cellulite
  • Impaired microcirculation associated with cellulite

Zastosowanie profesjonalne

Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.

Obszary zabiegowe

  • Cellulite-affected areas of the thighs and gluteal/trochanteric region

Profil pacjenta

Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.

Jak działa Sunekos Cell 15 ​

Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty SUNEKOS z pełną identyfikowalnością partii, produktami z oznakowaniem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.

Najczęściej zadawane pytania

Which cellulite stages does Sunekos Cell 15 treat?

Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.

How does Sunekos Cell 15 differ from lipolytic cellulite treatments?

Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.

Why does Sunekos Cell 15 include an alkaline solution?

The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.

Więcej od Professional Dietetics

Zobacz laboratorium →
* Produkt do użytku profesjonalnego. Opakowanie może się różnić w zależności od partii lub rynku. Pełne zalecenia i przeciwwskazania znajdziesz w dołączonej instrukcji użycia (IFU).